CCCZ Lighthouse Project
IMMUNO-CAR ZURICH (ZURICAR)
IMMUNO-CAR ZURICH (ZURICAR) aims to develop innovative platforms within the CCCZ for the effective, flexible, safe and cost-efficient production of Chimeric Antigen Receptor (CAR) immune cells. These are genetically manipulated immune cells produced by the body. These specifically dock onto the cancer cells and destroy them. The cell products will be manufactured at Wyss Zurich and subsequently used in Phase I clinical trials in patients with urgent need for effective therapies. This highly translational, patient-centered approach is accompanied by state-of-the-art immune monitoring during therapy and research to improve the efficacy of CAR cells. Learn more here.